Follow-The-Filings

Security

Aurinia Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

9 owners max 0.0% (Two Sigma Investments, LP)

owners 9
max % 0.0%
tracked value $153M
qoq A 5 R 3

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.04 pp 1,962,742 $31M hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 1,663,835 $25M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 1,874,597 $28M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Add 0.00 pp 1,572,983 $23M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 948,810 $14M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 168,598 $2M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 1,449,884 $23M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 274,574 $4M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 117,169 $2M hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $34.41M $50.3M $62.46M
Gross profit * $20.26M $22.06M $29.8M
Gross margin * 58.9% 43.8% 47.7%
Net income -$26.21M -$10.75M $23.34M
Net margin * -76.2% -21.4% 37.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $424.8M $446.6M $491.97M
Total non-current assets * $123.26M $104.05M $259.62M
Total assets $548.06M $550.64M $751.59M
Total current liabilities $77.19M $97.76M $93.72M
Total non-current liabilities * $92.92M $75.4M $76.53M
Total equity $377.95M $377.48M $581.33M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$33.46M $44.39M $135.66M
Cash from investing -$6.71M $39.26M -$32.77M
Cash from financing -$5.13M -$49.09M -$106.11M
Net change in cash -$45.3M $34.56M -$3.22M

ownership over time

filing count by report period · click a bar for that quarter’s holders